Skip to menu Skip to content Skip to footer
Banner only

PhD scholarship: Developing new treatments for children with brain cancer

Enrolment status
Future UQ student
Student type
Domestic, International
Study level
Postgraduate research (HDR)
Study area
Health and medicine
Scholarship focus
Academic excellence
Funding type
Living stipend, Tuition fees
Scholarship value
$28,854 per annum (2022 rate), indexed annually
Scholarship duration
3.5 years with the possibility of 1 extension in line with UQ and RTP Scholarship Policy
Number awarded
May vary
Applications open
8 March 2022
Applications close
20 September 2022

About this scholarship

Supervisor: Professor Brandon Wainwright

Brain cancer is the most common cause of cancer-related death in children. The Wainwright laboratory discovered the first gene known to cause brain tumours in children and since that time has been focused on using genetic/genomic and developmental biology approaches to understand the genesis of paediatric brain tumours and develop new therapies. The Children's Brain Cancer Initiative based at UQDI is a collaboration between multiple Universities and Research Institutes, and the Queensland Children's Hospital.  As part of this Initiative we have PhD scholarships for suitably qualified applicants.

Research environment

The University of Queensland Diamantina Institute

The University of Queensland Diamantina Institute (UQDI) was established in 2007 and forms a major research centre within the Faculty of Medicine. The aim of the Institute is to develop a better understanding of the molecular and cellular basis of disease, and to translate that understanding into practical outcomes for patients. Based at the Translational Research Institute (TRI) at the Princess Alexandra Hospital teaching campus in Brisbane, UQDI has more than 300 researchers, clinical academics and students who work closely with hospital clinicians in the areas of cancer, immunology, genomics and other areas of translational medicine. UQDI has particular research strengths in skin cancers, blood cancers and autoimmunity.

UQDI has a mission of translating discoveries into better treatments and has a strong record of achievement, most notably in the development of cancer therapies: research at UQDI by Professor Ian Frazer AC FRS led to the development of the cervical cancer vaccine Gardasil. UQDI is the largest partner in the TRI, which is an extremely well-equipped translational biomedical research institute, with outstanding laboratories and core facilities for imaging, microscopy, flow-cytometry and in vivo models of disease. Its close affiliation with clinical units at Princess Alexandra Hospital provides UQDI with a significant strategic advantage in near-patient, translational research. 

UQDI is part of The University of Queensland, one of the top Australasian universities, and internationally is ranked in the top 100 universities in all major independent rankings. UQDI academics are part of a vibrant and highly successful academic institution optimising their chances of research success. Details of the research interests of academic staff may be accessed on the Institute’s website.

Eligibility

You're eligible if you meet the entry requirements for a higher degree by research.

How to apply

Before submitting an application you should:

You apply for this scholarship when you submit an application for a Doctor of Philosophy (PhD). You don't need to submit a separate scholarship application.

When you apply, please ensure that under the scholarships and collaborative study section you:

  1. Select ‘My higher degree is not collaborative’
  2. Select 'I am applying for, or have been awarded a scholarship or sponsorship'.
  3. Select ‘Other’, then ‘Research Project Scholarship’ and type in ‘BRAIN CANCER-WAINWRIGHT’ in the 'Name of scholarship' field.

Selection criteria

Your application will be assessed on a competitive basis.

We take into account your:

  • previous academic record
  • publication record
  • honours and awards
  • employment history

A background or knowledge of cell and molecular biology and genetics/genomics is highly desirable.

Rules

A domestic part-time student with carer’s responsibilities, a medical condition or a disability, which prevents them from studying full time may be eligible for scholarship consideration, on a case by case basis.

Contact

Professor Brandon Wainwright